Efficacy of Hydroquinone 2% cream versus Tranexamic Acid Injectio
Not Applicable
- Conditions
- Condition 1: Melasma. Condition 2: melasma.
- Registration Number
- IRCT2017040533244N1
- Lead Sponsor
- Deputy of Research and Technology of Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 37
Inclusion Criteria
All patients with melasma
Exclusion criteria: Patients treated with steroids; Hydroquinone; Tretinoin; Azaleacic Acid and Kojic Acid; or pregnant; will be excluded. In addition, patients who have taken OCP over the past 12 months and who are taking light-sensitive drugs such as tetracycline; spironolactone; phenytoin and carbamazepine; or coagulation disorders and taking anticoagulant drugs will also be excluded.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Melasma and Melanin Density in Skin. Timepoint: Each 1 month. Method of measurement: Analysis with Dermacath.
- Secondary Outcome Measures
Name Time Method The Subjective Patient Satisfaction. Timepoint: After 3 month. Method of measurement: By VAS system.